Company Search:
Advanced Search
Sponsored Links
Oncoarendi Therapeutics SA Company Snapshot
Oncoarendi Therapeutics SA operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oncoarendi Therapeutics SA with three other pharmaceutical manufacturers in Europe: Irlab Therapeutics Ab of Sweden (2018 sales of 18,000.00 Swedish Kronor [US$1,834.92 ] ), NUTEX Investments Plc of Hungary (4.13 million Hungarian Forints [US$13,752.90 ] ), and Index Pharmaceuticals Holding Ab which is based in Sweden (128,000.00 Swedish Kronor [US$13,048.32 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Oncoarendi Therapeutics SA
  Stock Performance Chart for Oncoarendi Therapeutics SA
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): 11.20
(Figures in Polish New Zlotys)
1 Week -6.3%   13 Weeks 12.0%  
4 Weeks -6.7%   52 Weeks -43.9%  
Oncoarendi Therapeutics SA Key Data:
  Ticker: OAT Country: Poland
  Exchanges: WAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 3,000
(Year Ending Jan 2019).
Employees: 84
  Currency: Polish New Zlotys Market Cap: 153,104,000
  Fiscal Yr Ends: December Shares Outstanding: 13,670,000
  Share Type: AKCJE Closely Held Shares: 3,630,750
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.